Pharmacology and Drug Treatment

Active Projects: 58

Project Investigator All Topics Start date
End date
Phase 3, Randomized, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System (20 Mcg/Day) and Mirena® for Long-Term, Reversible Contraception up to Five Years Philip D. Darney, MD, MS Pharmacology and Drug Treatment, Family Planning
A Single Arm, Open-Label, Multicenter Study Evaluating the Long-Term Safety, Tolerability and Efficacy of 0.5 Mg Fingolimod (Fty720) Administered Orally Once Daily in Patients with Multiple Sclerosis (MS) Douglas S. Goodin, MD Pharmacology and Drug Treatment, Neurology and Mental Health
UCSF-GIVI Center for AIDS Research (CFAR) Paul A. Volberding, MD HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians
Center for RNA Systems Biology Jonathan S. Weissman, PhD Immunology, Genetics, Pharmacology and Drug Treatment
Futility Study of Deferoxamine in Intracerebral Hemorrhage "DIMINIsH" Vineeta Singh, MD Cardiovascular Disease, Pharmacology and Drug Treatment
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial Nisha Acharya, MD Eye Disease and Blindness, Pharmacology and Drug Treatment
A Two-Part, Open-Label, Single-Arm Phase 1/2 Study of Safety, Pharmacokinetics, and Efficacy of Telaprevir in Combination with Peginterferon alfa-2b and Ribavirin in Pediatric Subjects Aged 3 to 17 Infected With Genotype 1 Hepatitis C Virus Philip Rosenthal, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment, Pediatrics
Phase 1b Study of SAR650984 in Combo with Lenalidomide and Dexa for Treatment of Relapsed or Refractory Multiple Myeloma Thomas G. Martin, MD Cancer/Oncology, Drug and Diagnostics Development, Pharmacology and Drug Treatment
Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Active Ankylosing Spondylitis Lianne S. Gensler, MD Pharmacology and Drug Treatment
A Phase I/IIa Study of Safety and Efficacy of Alpharadin® with Docetaxel in Patients with Bone Metastases From Castration Resistant Prostate Cancer Charles J. Ryan, MD Cancer/Oncology, Pharmacology and Drug Treatment
Three Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) Alan P. Venook, MD Cancer/Oncology, Drug and Diagnostics Development, Pharmacology and Drug Treatment
PNOC-002: Safety, Phase 0, and Pilot Efficacy Study of vemurafenib, an oral inhibitor of BRAFV600E, in Children with Recurrent/Refractory BRAFV600E-mutant gliomas Michael D. Prados, MD Cancer/Oncology, Pharmacology and Drug Treatment, Pediatrics
A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human), Civacir®, in Orthotopic Liver Transplant Recipients Norah A. Terrault, MD Infectious Disease, Pharmacology and Drug Treatment
Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Study Evaluating the Impact of Serum-Derived Bovine Immunoglobulin Protein Isolate, a Medical Food, on Nutritional Status in HIV+ Subjects with HIV-Associated Enteropathy Ma Somsouk, MD, MAS Immunology, Pharmacology and Drug Treatment
Cannabinoid-based therapy and approaches to quantify pain in sickle cell disease Donald Abrams, MD Noncommunicable and/or Chronic Disease, Pharmacology and Drug Treatment
Systems Pharmacology Approaches to Understanding Drug Induced Weight Gain Kathleen M. Giacomini, PhD Pharmacology and Drug Treatment
Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Eye Disease and Blindness, Pharmacology and Drug Treatment
SFBay CTU Diane V. Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Thai Red Cross S&S, HPV TA008 Joel Palefsky, MD Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology, Pharmacology and Drug Treatment
Associate Dean for Global Health and Educational Innovations UCSF School of Pharmacy Tina Brock, MS, EdD Pharmacology and Drug Treatment, Health Economics and Policy, Access or Barriers to Care, International Health Policy, Health Systems Strengthening
Phase 2, Open-Label, Multicenter, Multi-cohort, Single-Arm Study to Investigate the Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children with Genotype 2 or 3 Chronic HCV Infection Philip Rosenthal, MD Infectious Disease, Pharmacology and Drug Treatment
Evaluation of technetium Tc 99m tilmanocept (Lymphoseek) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage from KS Lesions by SPECT and SPECT/CT Imaging Toby A. Maurer, MD HIV/AIDS, Cancer/Oncology, Pharmacology and Drug Treatment
Role of ABCG2 in the disposition and anti-hyperuricemic effects of allopurinol Kathleen M. Giacomini, PhD Pharmacology and Drug Treatment
Established Status Epilepticus Treatment Trial (ESETT) Daniel H. Lowenstein, MD Pharmacology and Drug Treatment, Neurology and Mental Health
Study to determine serum and skin biopsy biomarkers in patients receiving topical corticosteroid (TCS) and following TCS withdrawal (GNE-AD) Pharmacology and Drug Treatment
A Phase 3, Open-Label, Randomized, Parallel, 2-Arm, Multi-Center Study of BMN 673 versus Physician's Choice in Germline BRCA Mutation Subjects with Locally Advanced and/or Metastatic Breast Cancer, Who Have Received No More than 2 Prior Chemotherapy Hope Rugo, MD Cancer/Oncology, Pharmacology and Drug Treatment
Pharmacodynamics of Antimalarial Chemoprevention Philip J. Rosenthal, MD Malaria, Pharmacology and Drug Treatment
Phase 1 Open Label, Multi-center Study to Assess the Safety, tolerability and Pharmacokinetics of Orally administered CUDC-907, an HDAC and PI3K Inhibitor in Subjects with Advanced/ Relapsed Solid Tumors Pamela N. Munster, MD Cancer/Oncology, Pharmacology and Drug Treatment
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting Norah A. Terrault, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD) R. Keith McBurnett, PhD Pharmacology and Drug Treatment, Neurology and Mental Health
Phase 2a, Randomized, Placebo-controlled, Proof of Mechanism Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Subjects with Primary Sjogren's Syndrome Maria Dall'Era, MD Eye Disease and Blindness, Oral Health, Pharmacology and Drug Treatment
Clinical Pharmacology, Drug Action and Pharmacogenetics Esteban G. Burchard, MD, MPH Pharmacology and Drug Treatment, Residencies, Fellowships, and Postdoctoral Training
BA phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of etrolizumab as an induction and maintenance treatment for patients with moderately to severely active Crohn's disease Pharmacology and Drug Treatment
Allosteric Inhibition of a Family of Proteolytic Enzymes Charles S. Craik, PhD Immunology, Pharmacology and Drug Treatment
A Phase 2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Advanced Non-small Cell Lung Carcinoma Cancer/Oncology, Pharmacology and Drug Treatment
A Phase 1b/2 Study of the Oral CDK4/6 Inhibitor LEE011 in Combination with Docetaxel plus Prednisone in Metastatic Castration Resistant Prostate Cancer Rahul R. Aggarwal, MD Cancer/Oncology, Pharmacology and Drug Treatment
Phase 2, Parallel-Arm Study of MGCD265 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Activating Genetic Alterations in Mesenchymal-Epithelial Transition Factor Cancer/Oncology, Genetics, Pharmacology and Drug Treatment
Clinical Trial to Evaluate the Safety and Efficacy of the HeartAssist 5® VAD System compared to the HeartMate II® VAD for Left Ventricular Support in Patients Awaiting Cardiac Transplantation Georg M. Wieselthaler, MD Cardiovascular Disease, Pharmacology and Drug Treatment
A Study of the Safety, Immunopharmacodymics and Anti-TumorActivity of Ibrutinib Combined with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma Margaret A. Tempero, MD Cancer/Oncology, Pharmacology and Drug Treatment
Actelion - AC-065A304 Multicenter, open-label, single-group study to assess the tolerability and the safety of the TRANSITion from inhaled tresprostinil to oral selexipag in patients with pulmonary arterial hypertension 20150803 Cardiovascular Disease, Pharmacology and Drug Treatment
Phase II Study of MK-3475 with and without Bevacizumab for Recurrent Glioblastoma Jennifer L. Clarke, MD, MPH Cancer/Oncology, Pharmacology and Drug Treatment
An Expanded Access Protocol of Oral Rociletinib (CO-1686) as Epidermal Growth Factor Receptor (EGFR)-Directed Therapy for Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) with the T790M Resistance Mutation Cancer/Oncology, Pharmacology and Drug Treatment
Phase 1, Dose-Escalation and Expansion, Safety, pK, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation Cancer/Oncology, Pharmacology and Drug Treatment
ADXS31-142 in Combination with Pembrolizumab (MK-3475) in Patients with Previously Treated Metastatic Castration-Resistant Prostate Cancer Lawrence Fong, MD Cancer/Oncology, Pharmacology and Drug Treatment
Interventional Study to Assess the Safety and Efficacy of Pharmaceutical Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Subjects With Inadequately Controlled Lennox-Gastaut Syndrome Pharmacology and Drug Treatment, Neurology and Mental Health
A Phase 1 Open-Label, Dose-Finding Study Evaluating Safety and Pharmacokinetics of FPA144 in Patients with Advanced Solid Tumors Cancer/Oncology, Pharmacology and Drug Treatment
Molecular Mechanisms Underlying Tumor Progression Despite Enzalutamide Treatment Eric J. Small, MD Cancer/Oncology, Pharmacology and Drug Treatment
A Long-Term, Non-Interventional Registry to Assess Safety and Effectiveness of Humira (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease (CD)-CAPE Pharmacology and Drug Treatment
Service Agreement - HALO-109-301 Study Margaret A. Tempero, MD Cancer/Oncology, Pharmacology and Drug Treatment
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin plus Olaratumab versus Doxorubicin plus Placebo in Patients with Advanced or Metastatic Soft Tissue Sarcoma Cancer/Oncology, Pharmacology and Drug Treatment
CC 15957 A Phase 1, Open-Label Dose Escalation First-in-Human Study to Evaluate the Tolerability, Safety, Maximum Tolerated Dose, and Pharmacokinetics of AM0010 in Patients with Advanced Solid Tumors Cancer/Oncology, Pharmacology and Drug Treatment
Phase III Global Study of MEDI4736 in Combination with Tremelimumab Therapy or MEDI4736 Monotherapy vs Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patients with Locally Advanced or Metastatic Non Small-Cell Lung Cancer Cancer/Oncology, Pharmacology and Drug Treatment
The gut microbiome: an unexpected contributor to cancer drug resistance Peter J. Turnbaugh, PhD Cancer/Oncology, Immunology, Pharmacology and Drug Treatment
Pediatric drug dosing in very low resource environments Melissa Clark, MD Malnutrition, Micronutrients, Food Insecurity, Pharmacology and Drug Treatment, Immigration and Migration, Systematic Reviews and Guideline Development
Comparison of Pharmacologic Markers of Exposure to HIV Pre-Exposure Prophylaxis David V. Glidden, PhD HIV/AIDS, Pharmacology and Drug Treatment
A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination with Tremelimumab in Subjects with Advanced Non-small Cell Lung Cancer Cancer/Oncology, Pharmacology and Drug Treatment
Phase III multicenter multicenter, randomized, double-blind, placebo controlled, parallel group efficacy and safety study of Crenezumbab in patients with propromal to mild Alzheimers disease Adam L. Boxer, MD, PhD Pharmacology and Drug Treatment, Neurology and Mental Health
Antimalarial drugs in Ugandan populations Melissa Conrad, PhD HIV/AIDS, Malaria, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Pediatrics

Active Projects: 157

Project Investigator All Topics Start date
End date
Optimizing Management of Transient Ischemic Attacks Cardiovascular Disease, Pharmacology and Drug Treatment
Immediate Salvage Therapy w/ Combination ART plus T-20 vs. A 16 Week Structured Treatment Interruption Followed by Combination Therapy plus T-20 Steven G. Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts (SILCAAT) James G. Kahn, MD, MPH HIV/AIDS, Pharmacology and Drug Treatment, Health Economics and Policy
Host Protein Degradation by Schistosome Parasites Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Twelve-Week Study Evaluating the Safety and Efficacy of Varenicline Tartrate ( CP-526,555) in Comparison to Zyban for Smoking Cessation Victor I. Reus, MD Pharmacology and Drug Treatment, Smoking and Tobacco
Interruption of Enfuvirtide in Patients Experiencing an Incomplete Virologic Response to Enfuvirtide-Based Combination Antiretroviral Regimen Steven G. Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
Misoprotsol versus Placebo with Laminaria for Cervical Ripening before Late Second Trimester Abortion Philip D. Darney, MD, MS Pharmacology and Drug Treatment, Family Planning
Medical Pharmacy Consultation Team E. Michael Reyes, MD, MPH HIV/AIDS, Pharmacology and Drug Treatment
Targeting Cysteine Proteases--Antiparasitic Chemotherapy Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Eliminating Trachoma with Repeat Mass Drug Treatment Thomas M. Lietman, MD Eye Disease and Blindness, Pharmacology and Drug Treatment
Enfuvirtide Intensification for Multi-Drug Resistant HIV Steven G. Deeks, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of a Novel CCR5 Antagonist, UK427,857, for the Treatment of Antiretroviral-Experienced HIV-1-Infected Subjects Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Medical Pharmacy Consultation Team E. Michael Reyes, MD, MPH HIV/AIDS, Pharmacology and Drug Treatment
A Pilot Study of FOLFOX in Combination with Bevacizumab in Patients with Advanced Neuroendocrine Tumors Emily Bergsland, MD Cancer/Oncology, Pharmacology and Drug Treatment
What is the Appropriate Frequency and Duration of Mass Azithromycin Thomas M. Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
Clinical Pharmacology, Drug Action and Pharmacogenetics Neal L. Benowitz, MD Drug and Diagnostics Development, Pharmacology and Drug Treatment
San Francisco National Clinical Trial Center, ESPIRIT Steven G. Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
Development of Regulatory T-Cells for Treatment of Autoimmune Disease Jeffrey A. Bluestone, PhD Immunology, Pharmacology and Drug Treatment
Assessing Antiretroviral Exposure in Diverse Populations Monica Gandhi, MD, MPH HIV/AIDS, Pharmacology and Drug Treatment
The Steroids for Corneal Ulcers Trial Thomas M. Lietman, MD Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment
High Throughput Assay for Screening Compounds Against T. Brucei Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Optimization of Cysteine Protease Inhibitors Targeting Trypanosoma Brucei Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
Quality Assurance/Quality Control Program Francesca T. Aweeka, PharmD Pharmacology and Drug Treatment
A phase III trial to investigate the efficacy, tolerability & safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected OBR in HIV-1 infected subjects w/ limited to no treatment options Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
CASTIA Neurological Core Imaging Lab (NCIL) Cardiovascular Disease, Pharmacology and Drug Treatment, Neurology and Mental Health
Enfuvirtide Treatment Intensification in Patients with Multi-Drug Resistant HIV Steven G. Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
Antiplatelet Therapy for Ischemic Stroke and Transient Ischemic Attack in U.S. Community Hospitals Cardiovascular Disease, Pharmacology and Drug Treatment
Ceftobiprole vs. Daptomycin and Linezolid for Treatment of Experimental Staph. aureus Endocarditis in Rabbits Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
Randomized Controlled Trial of 6% Cellulose Sulfate Gel and the Effect on Vaginal HIV Transmission Ariane Van der Straten, PhD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Pharmacology and Drug Treatment
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS Laurence Huang, MD HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Transcriptional Responses of Parasite and Host during Intestinal Colonization and Invasion by Entamoeba histolytica Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment
MAPS: Matrix And Platinum Science, A Prospective, Randomized, Multicenter, Trial Investigating Matrix2 tm and GDC? Coils for the treatment of intracranial saccular aneurysms Trial Cardiovascular Disease, Pharmacology and Drug Treatment
Protocol Development for a Phase 2 Study Evaluating the Safety and Feasibility of Ceftobiprole Compared to Conventional Therapy in the Treatment of Subjects w/ Staphylococcus aureus Bacteremia Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
Tibotec TMC125-C214: Early Access of TMC125 in Combination with Other Antiretrovirals in Treatment-Experienced HIV-1 Infected Subjects with Limited Treatment 0ptions Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Phase 2 Study, Safety of and Rate of Bacterial Clearance of Ceftobiprole Compared to Conventional Therapy in the Treatment of Subjects w/ Staphylococcus aureus Bacteremia Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
Task Order #1 RAMPART Study - Neurological Emergencies Treatment Trials J. Claude Hemphill, MD Pharmacology and Drug Treatment, Neurology and Mental Health
Pharmacogenomics of Antimalarial Drugs Sunil Parikh, MD, MPH Malaria, Genetics, Pharmacology and Drug Treatment
Adjuvant Treatment with Temodar plus Avastin Alone or with Tarceva in Patient with Newly Diagnosed Glioblastoma Multiforme Who Are Stable Following Radiotherapy with Temodar Michael D. Prados, MD Cancer/Oncology, Pharmacology and Drug Treatment
A Phase 2, Randomized, Open-Labeled Study on the Safety of and Rate of Bacterial Clearance of Ceftobiprole Compared to Conventional Therapy in the Treatment of Subjects w/ Staphylococcus aureus Bacteremia Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
Role of Buprenorphine in Improving Clinicial Care in Opioid Addiction and HIV Elinore F. McCance-Katz, MD, PhD HIV/AIDS, Pharmacology and Drug Treatment, Substance Abuse
Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus Mandana Khalili, MD Infectious Disease, Pharmacology and Drug Treatment
Phase II Study of 7 Days On/7 Days Off Temozolomide in Patients with High Grade Glioma Nicholas Butowski, MD Cancer/Oncology, Pharmacology and Drug Treatment
Research to Programs for Trachoma Elimination Thomas M. Lietman, MD Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance
A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Prophylactic Use of Maribavir Versus Oral Ganciclovir for the Prevention of Cytomegalovirus Disease in Recipients of Orthotopic Liver Transplants Peter Chin-Hong, MD Opportunistic Infection, Pharmacology and Drug Treatment
Phase IV Open-Label, Non-comparative Trial of IV Anidulafungin followed by Oral Azole Therapy for the Treatment of Candidemia and Invasive Candidiasis Peter Chin-Hong, MD HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Entecavir Intensification for HIV-HBV Coinfected subjects with persistent HBV viremia Anne F. Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
HIV Emergence of Drug Resistance Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
Pfizer A4001027: Observational Phase Extension Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
A8851009: A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to that of Voriconazole Alone When Used For Primary Therapy of Proven or Probable Invasive Aspergillosis Peter Chin-Hong, MD Opportunistic Infection, Pharmacology and Drug Treatment
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection Priscilla Y. Hsue, MD HIV/AIDS, Cardiovascular Disease, Pharmacology and Drug Treatment
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease Chronic Respiratory Disease, Pharmacology and Drug Treatment
Protocol # ADMA-001: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Trial Evaluating the Safety and Efficacy of RI-001 in Medically Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Peter Chin-Hong, MD HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Replication fidelity mutants as attenuated poliovirus seeds for IPV production Raul Andino-Pavlovsky, PhD Drug and Diagnostics Development, Pharmacology and Drug Treatment
Tetrezolid vs. Daptomycin and Vancomycin for Treatment of Experimental Staphylococcus aureus Henry Chambers, MD Infectious Disease, Pharmacology and Drug Treatment
Tenofovir Kidney Toxicity Study Kathleen M. Giacomini, PhD HIV/AIDS, Pharmacology and Drug Treatment
Study of Three NNNRTI-Sparing Antiretroviral Regimens for Treatment-Naive HIV-1-Infected Volunteers (ACTG A5257) Diane V. Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects (ATCG A5262) Diane V. Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Task Order #3: Protect II Study - Neurological Emergencies Treatment Trial J. Claude Hemphill, MD Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD
Quality of Sleep in HIV-Infection: Association with Treatment and Adherence Parya Saberi, PharmD HIV/AIDS, Pharmacology and Drug Treatment, Treatment Adherence
The Impact of Anogenital Human Papillomavirus in the Transmission of HIV in Urban Brazil: Phase II Study Joel Palefsky, MD Infectious Disease, Pharmacology and Drug Treatment
Mycotic Ulcer Treatment Trial Thomas M. Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
Early Mortality in HIV-Infected Patients Starting Antiretroviral Therapy in Africa Elvin H. Geng, MD, MPH HIV/AIDS, Pharmacology and Drug Treatment
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven G. Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
Therapeutic Effects of Pharmacological Manipulation of Intracellular Nitric Oxide Levels in Cardiovascular Disease Matthew Springer, PhD Cardiovascular Disease, Pharmacology and Drug Treatment
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A Diane V. Havlir, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Phase III Clinical Trial "Platelet Oriented Inhibition in New Tia" - Drug: Plavix Cardiovascular Disease, Pharmacology and Drug Treatment
Study of Oral UT-15C Subjects with Pulmonary Arterial Hypertension Vijay P. Balasubramanian, MD, MRCP Noncommunicable and/or Chronic Disease, Pharmacology and Drug Treatment
Protocol AI463-189-004: A Comparative Study of the Antiviral Efficacy and Safety of Entecavir (ETV) Philip Rosenthal, MD HIV/AIDS, Pharmacology and Drug Treatment
Gilead GS-US-236-0102 Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Phase 1b, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of MEGF0444A, A Humanized 1gG1 Antibody in Combination with Bevacizumab with or without Paclitaxel in Patients with Locally Advanced or Metastatic Solid Tumors Pamela N. Munster, MD Cancer/Oncology, Pharmacology and Drug Treatment
Task Order Supplement to A5267 Diane V. Havlir, MD HIV/AIDS, Tuberculosis, Pharmacology and Drug Treatment
Task Order # 9: Supplement to SSS A5272 Diane V. Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Ultrasensitive Monitoring of HIV-1 Drug Resistance Reversion Following Transmission with Drug Resistant Virus Teri Liegler, PhD HIV/AIDS, Pharmacology and Drug Treatment, Women's Health, Newborn and Infant Health
PAAR4Kids-Pharmacogenomics Research Network Mignon Loh, MD Cancer/Oncology, Genetics, Pharmacology and Drug Treatment
Expanded Access to MGAWN1 in Subjects with Suspected West Nile Neuroinvasive Disease; Substantial Exposure, or Infection and a Compromised Immune System Jeffrey W. Ralph, MD Zoonosis, Emerging Disease, and Drug Resistance, Pharmacology and Drug Treatment
TANA II Thomas M. Lietman, MD Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance
Efficacy and Safety of Eraxis/Ecalta (Anidulafungin) Compared to Cancidas (Caspofungin) in Patients with Candida Deep Tissue Infection: A Phase 4 Study Peter Chin-Hong, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Misoprostol for Prevention or Early Treatment Suellen Miller, PhD, CNM, MHA Pharmacology and Drug Treatment, Labor and Delivery
Individually Optimized Conditioning Using PK-directed Dose Adjustment of Once Daily IV Busulfan, Followed by Autologous Hematopoietic Stem Cell Transplant Ai Z. Weiyun, MD, PhD Cancer/Oncology, Pharmacology and Drug Treatment
Genetic and Chemical Biological Studies of K2P Structure, Function, and Modulation Daniel Minor, JR, PhD Noncommunicable and/or Chronic Disease, Cardiovascular Disease, Pharmacology and Drug Treatment, Neurology and Mental Health, Risk Reduction and Prevention
Oral Drug Treatment for Enhanced Immune Control over HIV Replication Dennis Hartigan-O'Connor, MD, PhD HIV/AIDS, Pharmacology and Drug Treatment
Tobira 652-2-202 Pre-Clinical Trial Cost Agreement Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
A postmarketing observational study to assess respiratory tract adverse events in pulmonary arterial hypertension patients treated with Tyvaso® (treprostinil) inhalation solution Vijay P. Balasubramanian, MD, MRCP Pharmacology and Drug Treatment
Synthetic Biology Engineering Research Center (SynBERC) Wendell A. Lim, PhD Drug and Diagnostics Development, Genetics, Pharmacology and Drug Treatment
Phase 1 Iontophoretic Delivery of Dexamethasone for Tx of Anterior Scleritis Nisha Acharya, MD Eye Disease and Blindness, Drug and Diagnostics Development, Pharmacology and Drug Treatment
WSA-CS-003: Open Label Study of Isavuconazole in the Treatment of Patients with Aspergillosis and Renal Impairment or of Patients with Invasive Fungal Disease Caused by Rare Molds, Yeasts or Dimorphic Fungi Peter Chin-Hong, MD Infectious Disease, Opportunistic Infection, Pharmacology and Drug Treatment
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts Vivek Jain, MD HIV/AIDS, Pharmacology and Drug Treatment
Neurological Emergencies Treatment Trials: Clinical Coordinating Center (NETT CCC) Daniel H. Lowenstein, MD Pharmacology and Drug Treatment, Neurology and Mental Health
Iontophoresis Delivery of Dexamethason Phosphate for Non-Infectious, No-Necrotizing Anterior Scieritis, Phase I Dose-Varying Study Nisha Acharya, MD Eye Disease and Blindness, Pharmacology and Drug Treatment
Task Order A5303: Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naive Patients Infected with R5-Tropic HIV-1 Diane V. Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Rifaximin Treatment of Moderate to Severe Papulopustular Rosacea: Double-Blinded, Placebo-Controlled, Crossover Study Martin Steinhoff, MD, PhD Pharmacology and Drug Treatment
AIDS Clinical Trials Network (ACTG)-Deeks (Co-Vice Chair) A5296 Steven G. Deeks, MD HIV/AIDS, Noncommunicable and/or Chronic Disease, Pharmacology and Drug Treatment
Navigating the Scientific Evidence to Ensure Prevention Tracey Woodruff, PhD, MPH Occupational and Environmental Disease, Pharmacology and Drug Treatment, Systematic Reviews and Guideline Development, Epidemiology and Surveillance
JBAL: A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate plus Lomustine Therapy compared to Lomustine Monotherapy in Patients with Recurrent Glioblastoma Nicholas Butowski, MD Cancer/Oncology, Pharmacology and Drug Treatment
ACE-Inhibitors to Decrease Lymphoid Fibrosis and the Size of the Latent Reservoir in Antiretroviral-Treated, HIV-infected Patients: A Randomized, Placebo-Controlled Study Hiroyu Hatano, MD, MHS HIV/AIDS, Pharmacology and Drug Treatment
A Phase 4, Randomized, Double-Blind, Multicenter, Parallel-Group, Active-Controlled, Forced-Dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared with OROS-MPH (CONCERTA®) with a Placebo Reference Arm, in Adolescents Aged 13-17 Year R. Keith McBurnett, PhD Pharmacology and Drug Treatment, Neurology and Mental Health
Phase 4, Parallel Group, Active-Controlled, Dose-Optimization Study of SPD489 (Vyvanse) Compared with OROS-MPH (Concerta) with a Placebo Reference Arm, in Adolescents 13-17 with Attention-deficit/Hyperactivity Disorder R. Keith McBurnett, PhD Pharmacology and Drug Treatment
Pharmaceutical Sciences and Pharmacogenomics Deanna L. Kroetz, PhD Drug and Diagnostics Development, Pharmacology and Drug Treatment, Residencies, Fellowships, and Postdoctoral Training
P-S RPB - Assessing Corneal Ulcer Prevention with a Community-Randomized Trial Thomas M. Lietman, MD Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
Memantine in Pediatric Patients with Autism, Asperger Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Robert L. Hendren, DO Pharmacology and Drug Treatment, Neurology and Mental Health, Pediatrics
Pharmacogenetics of Chemotherapy-Induced Toxicity in Breast Cancer Deanna L. Kroetz, PhD Cancer/Oncology, Genetics, Pharmacology and Drug Treatment, Women's Health
The Human Epilepsy Project (HEP) Daniel H. Lowenstein, MD Pharmacology and Drug Treatment, Neurology and Mental Health
Amitriptyline and Topiramate in the Prevention of Childhood Migraine Peter J. Goadsby, MD, PhD Pharmacology and Drug Treatment
Short-Term Disulfiram Administration to Reverse Latent HIV Infection Steven G. Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
Genome-Wide Association Study to Examine Genes Associated with An Increased Risk of Febrile Seizure in Children Following Measles-Containing Vaccines Mark Seielstad, PhD Infectious Disease, Pharmacology and Drug Treatment, Pediatrics
Evaluation of Pomalidomide in Combination with High Dose Dexamethasone and Oral Cyclophosphamide in Patients with Relapsed and Refractory Myeloma Thomas G. Martin, MD Cancer/Oncology, Pharmacology and Drug Treatment
Nonlinear Mixed Effects Modeling of Rifapentine Pharmacokinetics Rada Savic, PhD Tuberculosis, Pharmacology and Drug Treatment
BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects with Mild Alzheimer's Disease Adam L. Boxer, MD, PhD Pharmacology and Drug Treatment, Neurology and Mental Health
Botulinum neurotoxin (BoNT) Collaboration James D. Marks, MD, PhD Occupational and Environmental Disease, Pharmacology and Drug Treatment
Genetic Determinants of Capecitabine Toxicity Hope Rugo, MD Genetics, Pharmacology and Drug Treatment
Preventing the Neonatal Narcotic Abstinence Syndrome (NAS) Juan E. Vargas, MD Pharmacology and Drug Treatment, Newborn and Infant Health, Substance Abuse
Tenofovir in Pregnancy (TIP) Study John A. Shepherd, PhD HIV/AIDS, Pharmacology and Drug Treatment, Women's Health, Newborn and Infant Health
Implantable multi-analyte sensors for the continuous monitoring of body chemistries Tejal A. Desai, PhD Pharmacology and Drug Treatment
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-Daily Oral Aripiprazole in Children and Adolescents with Tourette's Disorder R. Keith McBurnett, PhD Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Migraine Peter J. Goadsby, MD, PhD Pharmacology and Drug Treatment, Neurology and Mental Health
An Open Label Dose Finding Study of Nimodipine for the Treatment of Frontotemporal Dementia Due to Progranulin Insufficiency From GRN Gene Mutations Adam L. Boxer, MD, PhD Pharmacology and Drug Treatment
BEACON Study (BrEAst Cancer Outcomes with NKTR-102): Phase 3 Study of NKTR-102 versus Treatment of Physician's Choice (TPC) in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated with Anthracycline, a Taxane and Capecitabine Hope Rugo, MD Cancer/Oncology, Pharmacology and Drug Treatment, Women's Health
SOCRATES - Acute Stroke Or Transient Ischaemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes Cardiovascular Disease, Pharmacology and Drug Treatment
Genetic Predictors of Bevacizumab Toxicity in CALGB 80405 Deanna L. Kroetz, PhD Genetics, Pharmacology and Drug Treatment
Biotest Analysis for HCMV Infection in Placentas Lenore Pereira, PhD Infectious Disease, Pharmacology and Drug Treatment, Women's Health, Newborn and Infant Health
M13-099: Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis (TURQUOISE-II) Norah A. Terrault, MD Infectious Disease, Pharmacology and Drug Treatment
Pain Management in Clinic & Community Kelly R. Knight, PhD Pharmacology and Drug Treatment
Selectively targeting delta opioid receptor subtypes to control drinking behavior Jennifer L. Whistler, PhD Pharmacology and Drug Treatment, Substance Abuse
Compassionate Use of Marqibo for the Treatment of Refractory Lymphoblastic Leukemia/Leukemia Charalambos (Babis) Andreadis, MD Cancer/Oncology, Pharmacology and Drug Treatment
CT-based modeling to analyze variation in skeletal response to osteoporosis drugs Thomas F. Lang, PhD Pharmacology and Drug Treatment
Phase I Multiple Ascending Dose Trial of the MT Stabilizer TPI-287 for Alzheimer Disease (AD) Adam L. Boxer, MD, PhD Pharmacology and Drug Treatment, Dementia and Cognitive Impairment
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab(LY2062430) versus Placebo Adam L. Boxer, MD, PhD Pharmacology and Drug Treatment, Dementia and Cognitive Impairment
Effect of low dose methotrexate on endothelial function and inflammation in HIV - A5314 Diane V. Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 Coadministered with Ribavirin in Adults with Genotype 1 Chronic HCV and HIV Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Mechanism-Based Integrative Pharmacology Model for Tuberculosis Rada Savic, PhD Tuberculosis, Pharmacology and Drug Treatment
CC#14952: Phase IB Study of MK-3475 in Subjects with Select Advanced Solid Tumors Hope Rugo, MD Cancer/Oncology, Pharmacology and Drug Treatment
Financial Impact of the Current and Alternative Pricing Practices for Compounded, Co-packaged, and Over-the-Counter drugs and Medical Foods within the California Workers' Compensation System: Non-Formulary Impact if Pharmacy or Physician Dispensed Leslie Wilson, PhD, MS Pharmacology and Drug Treatment, Health Economics and Policy, Access or Barriers to Care
IMPAACT Yr 08 P1077 CTU MOU #2 - St. Mary's Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Pharmacology and Drug Treatment, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
Reconstitution of the gut microbiome to reduce systemic inflammation during treated HIV infection Ma Somsouk, MD, MAS HIV/AIDS, Pharmacology and Drug Treatment, Treatment Adherence
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Subjects with Chronic HCV GT1, GT4, GT5, and GT6 Infection who are on Opiate Substitution Therapy Anne F. Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
GS-US-342-1137: A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects with Chronic HCV Infection and Child-Pugh Class B Cirrhosis Norah A. Terrault, MD Pharmacology and Drug Treatment
Life After Pediatric Sepsis Evaluation, LAPSE Anil Sapru, MD Drug and Diagnostics Development, Pharmacology and Drug Treatment, Pediatrics
GS_US_342-1139: Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks with Sofosbuvir and Ribavirin for 12 Weeks in Subjects with Chronic Genotype 2 HCV Infecti Anne F. Luetkemeyer, MD Infectious Disease, Pharmacology and Drug Treatment
Targeting host autophagy for treating Mtb infections and synergizing with antibiotics in vivo Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment
Phase 1 Open-Label First-in-Human Dose-Escalating Safety and Tolerability Study Evaluating Subcutaneous Administration of Andes-1537 for Injection in Patients With Advanced Unresectable Malignancies That Are Refractory to All Standard Pamela N. Munster, MD Cancer/Oncology, Pharmacology and Drug Treatment
RAPID: Ebola virus population structure, genetic diversity and evolution Raul Andino-Pavlovsky, PhD Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment
CHRP Disparities Initiative: UCSF CFAR Conference Award Paul A. Volberding, MD HIV/AIDS, Drug and Diagnostics Development, Pharmacology and Drug Treatment
Vision to Discover New Treatments for Parkinson's and Other Neurodegenerative Diseases Stanley B. Prusiner, MD Pharmacology and Drug Treatment, Neurology and Mental Health
A Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 weeks in Subjects with Chronic HCV and HIV-1 Coinfection Anne F. Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
Consultancy to develop a global demand forecasting for malaria rapid diagnostic tests, artemisinin-based combination therapies and artemisinin Colin Boyle, MPP, MBA Pharmacology and Drug Treatment, Access or Barriers to Care
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Policy, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, International Health Policy, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations Matthew R. Cooperberg, MD Cancer/Oncology, Pharmacology and Drug Treatment
Comparative Effectiveness of Antiretroviral Therapy (ART) with Upfront Chemotherapy versus ART Alone in HIV-Infected Patients with Kaposi Sarcoma without Urgent Indications for Chemotherapy HIV/AIDS, Opportunistic Infection, Cancer/Oncology, Pharmacology and Drug Treatment
Development and validation for an HPLC-UV multiplex assay for therapeutic drug monitoring of antiretroviral drugs in Uganda Allan Buzibye, Bsc HIV/AIDS, Pharmacology and Drug Treatment
Protocol Development Co-Chair for Phase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of GSK 1349572, a novel integrase inhibitor, in combination regimens in HIV-1 Infected Infants, Children & Adolescents Theodore D. Ruel, MD HIV/AIDS, Pharmacology and Drug Treatment, Pediatrics, Adolescent Health
LOC-IMPAACT Leadership Group Francesca T. Aweeka, PharmD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health, Systematic Reviews and Guideline Development
Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection Steven R. Stoltz, MD Pharmacology and Drug Treatment
Provider Practices in Non-Malarial Fevers: A Pilot Study in Malawi Kimberly Baltzell, RN, PhD, MS Drug and Diagnostics Development, Pharmacology and Drug Treatment
Pharmacogenomics of Bronchodilator Response in Minority Children with Asthma Esteban G. Burchard, MD, MPH Chronic Respiratory Disease, Genetics, Pharmacology and Drug Treatment, Pediatrics
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa (PROMOTE) Diane V. Havlir, MD HIV/AIDS, Malaria, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health
Development of Rectal Enema As Microbicide (DREAM) Rada Savic, PhD HIV/AIDS, Pharmacology and Drug Treatment
he Efficacy of Various Antibiotics at Targeting Wolbachia for the Treatment of Lymphatic Filariasis Emma Gunderson, MS Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment